NCT07447856

A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain

Integrating Topical Herbal Plasters to Enhance Pain Management and Reduce Opioid Use in Cancer Patients (EASE)

• Status: Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: Memorial Sloan Kettering Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The are doing this study to find out whether using topical (on the skin) herbal plasters, Tibetree pain- relieving plasters (PRPs), can be an effective addition to standard opioid therapy for pain management. The researchers will look at whether the Tibetree PRPs are a practical (feasible) and effective way of managing localized pain (pain that is limited to a certain area) in people who are currently taking opioids. Participants in this study will have cancer or have had it in the past.

Conditions

• Cancer Patients
• Survivor Patients
• Cancer Pain

Interventions

Type	Name	Description
DRUG	Topical herbal plaster	Participants will receive topical herbal plaster once a day for up to 8 hours daily for 7 days.

Timeline

• Start date: 2026-02-23
• Primary completion: 2028-02-01
• Completion: 2028-02-01
• First posted: 2026-03-04
• Last updated: 2026-03-04

Locations

7 sites across 1 country: United States

Regulatory

• FDA-regulated drug study